January 01, 2026 — RNews

#eradication — Thursday, January 01, 2026 (1 items)

hot top new

← prev day next day →

0

Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial. (linkinghub.elsevier.com)

Song Z … Ma Z Lancet Infectious Diseases 2026-01-01

#infection #clinical trial #antibiotic #eradication